Antiviral/Covid-19 Therapy

Security Type
Min Investment
Del Mar, CA
Offering Date
January 12, 2021
Expected Close Date
December 31, 2021
Target Raise
Deal Notes

Pro-rata portion of total principal value raised; Notes will be sold in increments of $1.00 with a minimum investment of $100.00.

Company Description

About Medior is a biosciences company seeking to repurpose existing antiviral medications to treat SARS-CoV-2 (Covid-19). We are working on modifications in delivery format to use a known therapy to combat a novel virus. Reasons to Invest New drug development takes years and substantial capital investment; Repurposing existing therapies is faster and a fraction of the...

Amount Raised : $0
Reveal the Score by Voting
Not enough ratings to determine a viable CrowdScore for this deal.
The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.
The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.
Business Idea
The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.
Business Traction
The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.
Management Team
The value of the company compared to similar companies raising money from investors.

Security Description

A note is a financial security that generally has a longer term than a bill but a shorter term than a bond.

Research Reports

No reports have been submitted

Become a Reporter